Ionis Pharmaceuticals, Inc.
Compositions and methods for modulating growth hormone receptor expression

Last updated:

Abstract:

The present embodiments provide methods, compounds, and compositions for treating, preventing, or ameliorating a disease associated with excess growth hormone using antisense compounds or oligonucleotides targeted to growth hormone receptor (GHR).

Status:
Grant
Type:

Utility

Filling date:

4 Aug 2020

Issue date:

26 Apr 2022